SYNAGEVA BIOPHARMA CORP.

Profile

Company Names

SYNAGEVA BIOPHARMA CORP.
SYNAGEVA BIOPHARMA CORP

Addresses

128 SPRING STREET, SUITE 520, LEXINGTON, MA 02421

60 HICKORY DR., WALTHAM, MA 02451

Phone Numbers

781-357-9900
7818901111

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

> 5 years ago

State Incorporated:

DE

Total Amount Raised:

$57,499,973.00

Number of Funding Rounds:

2
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
2
2011-03-15 
$12,500,000.00 
$25,000,000.00 
$12,500,000.00 
Debt 
1
2009-04-01 
$44,999,973.00 
$45,000,000.00 
$27.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
SRINI 
 
AKKARAJU 
DIRECTOR
SYNAGEVA BIOPHARMA CORP.   |  SMM SPV I, LLC   |  ATYR PHARMA INC   |  CHINOOK THERAPEUTICS U.S., INC.   |  A2 BIOTHERAPEUTICS, INC.
FELIX 
 
BAKER 
DIRECTOR
SYNAGEVA BIOPHARMA CORP.   |  SYNAGEVA BIOPHARMA CORP   |  SEATTLE GENETICS INC /WA   |  PRESIDIO PHARMACEUTICALS, INC.   |  SLIPCHIP CORP   |  BAKER BROTHERS LIFE SCIENCES LP   |  HCIF OFFSHORE LP
FELIX 
J. 
BAKER 
DIRECTOR
SYNAGEVA BIOPHARMA CORP.   |  IGM BIOSCIENCES, INC.   |  BICYCLE THERAPEUTICS PLC
STEPHEN 
 
BIGGAR 
DIRECTOR
SYNAGEVA BIOPHARMA CORP.   |  SYNAGEVA BIOPHARMA CORP   |  BBDX, INC.   |  NEUROGENE INC.
STEPHEN 
R. 
BIGGAR 
DIRECTOR
SYNAGEVA BIOPHARMA CORP.   |  NOTCH THERAPEUTICS, INC.
MARK 
 
GOLDBERG 
DIRECTOR
SYNAGEVA BIOPHARMA CORP.   |  SYNAGEVA BIOPHARMA CORP   |  ATYR PHARMA INC   |  BUILT TECHNOLOGIES, INC.   |  PILOT.COM, INC.   |  BIOFEEDBACK DESIGN, INC.   |  KEEP TRUCKIN, INC.   |  MOTIVE TECHNOLOGIES, INC.   |  STIRLING HOTELS + RESORTS, INC.   |  CHEMISTRY VENTURES FUND I, L.P.   |  CHEMISTRY VENTURES FUND II-A, L.P.
LYLE 
 
HOHNKE 
DIRECTOR
ATRITECH INC   |  SYNAGEVA BIOPHARMA CORP.   |  SYNAGEVA BIOPHARMA CORP   |  CYTOMEDIX INC   |  BIOPONTIS ALLIANCE FUND I, L.P.   |  CONSORTIEX INC.
THOMAS 
 
MALLEY 
DIRECTOR
SYNAGEVA BIOPHARMA CORP.   |  SYNAGEVA BIOPHARMA CORP   |  PLAZA AMISTAD ASSOCIATES, L.P.   |  PLAZA AMISTAD ASSOCIATES II, L.P.   |  CAMINO GONZALEZ ASSOCIATES LP   |  AZAHAR PLACE ASSOCIATES, L.P.   |  OVASCIENCE, INC.   |  KURA ONCOLOGY, INC.
THOMAS 
R. 
MALLEY 
DIRECTOR
SYNAGEVA BIOPHARMA CORP.   |  INNOVATIVE ACQUISITIONS CORP   |  PUMA BIOTECHNOLOGY, INC.   |  PUMA BIOTECHNOLOGY, INC.
SANJ 
K. 
PATEL 
EXECUTIVE OFFICER, DIRECTOR
SYNAGEVA BIOPHARMA CORP.   |  SYNAGEVA BIOPHARMA CORP
ROBYN 
 
SAMUELS 
DIRECTOR
SYNAGEVA BIOPHARMA CORP.   |  SYNAGEVA BIOPHARMA CORP
JAMES 
 
TULLIS 
DIRECTOR
IKANO THERAPEUTICS INC.   |  SYNAGEVA BIOPHARMA CORP.   |  ELECTROCORE, LLC   |  ALPHATEC HOLDINGS, INC.
JAMES 
L.L. 
TULLIS 
DIRECTOR
TULLIS OPPORTUNITY FUND, L.P.   |  SYNAGEVA BIOPHARMA CORP.   |  TULLIS GROWTH FUND, L.P.   |  TULLIS GROWTH FUND CAYMAN FEEDER, L.P.   |  EXAGEN DIAGNOSTICS INC   |  SAFEOP SURGICAL, INC.   |  EXAGEN INC.   |  SUPPLYPRO INC   |  ELECTROCORE, INC.   |  TULLIS GROWTH FUND II, L.P.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2011-03-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Debt 
2011-03-15 
2010-08-02
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-04-01 
2009-05-07
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-04-01 
2009-04-16
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2009-04-01 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#